We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Yuanshu Pharmaceutical Technology Co.,Ltd. was established in 2015 in Nanjing ( Life Science and Technology Innovation Park ), which focus on medicines and fine electronic chemicals field , and be entitled as ' Jiangsu Good Enterprise ', awarded ISO 9001 certification in 2017, besides, as a ' National High Technology Enterprise ’honour in year 2018.Yuanshu was listed on the Science and Technology Innovation Board of Jiangsu Equity Trading Center in year 2020.
Yuanshu Pharmaceutical Technology Co., Ltd. has a modern R&D center in Jiangsu Life Science and Technology Innovation Park. We have international advanced equipments, management system and functional departments. Yuanshu focuses on the CRO and CDMO of clinical drug intermediates with high synthesis difficulty, and the development of ADC drug. The R&D has a professional process development team and follows strict confidentiality system and intellectual property protection system for customized projects. At present, 18 patents have been authorized and 11 patents have been accepted.
The concept of our company is to adhere to scientific and technological innovation is the source power of enterprise development! We will strive to become a professional manufacturer and supplier in the field of medicines and materials.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![4-[6-(6-BROMO-8-CYCLOPENTYL-5-METHYL-7-OXO-7,8-DIHYDRO-PYRIDO[2,3-D]PYRIMIDIN-2-YLAMINO)-PYRIDIN-3-Y](https://eimg.pharmasources.com/image/product/20230322/08da050772e40549f1e0ba9fa3c5ee8bjpg!145)
![2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzo[d][1,3,2]diazaborinin-4(1H)-one](https://eimg.pharmasources.com/image/20230711/8wHUpbjeVddSnkGEaeDCJ3Ghso6uDlBFF8nh6Piz.png!145)
![(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride](https://eimg.pharmasources.com/image/20221020/nxZrIR7S5RFIKPukvUoJzsFWteZfTzhYAtQkr8l2.jpeg!145)
